Search results
Results from the WOW.Com Content Network
The metastable technetium-99m (99m Tc) is a short-lived (half-life about 6 hours) nuclear isomer used in nuclear medicine, produced from molybdenum-99. It decays by isomeric transition to technetium-99, a desirable characteristic, since the very long half-life and type of decay of technetium-99 imposes little further radiation burden on the body.
Technetium-99m (99m Tc) is a metastable nuclear isomer of technetium-99 (itself an isotope of technetium), symbolized as 99m Tc, that is used in tens of millions of medical diagnostic procedures annually, making it the most commonly used medical radioisotope in the world.
The vast majority of the technetium-99m used in medical work is produced by irradiating dedicated highly enriched uranium targets in a reactor, extracting molybdenum-99 from the targets in reprocessing facilities, [40] and recovering at the diagnostic center the technetium-99m produced upon decay of molybdenum-99.
A Tc-99m pertechnetate solution is being eluted from Mo-99 molybdate bound to a chromatographic substrate. A technetium-99m generator, or colloquially a technetium cow or moly cow, is a device used to extract the metastable isotope 99m Tc of technetium from a decaying sample of molybdenum-99.
Technetium (99m Tc) sestamibi is a lipophilic cation which, when injected intravenously into a patient, distributes in the myocardium proportionally to the myocardial blood flow. Single photon emission computed tomography imaging of the heart is performed using a gamma camera to detect the gamma rays emitted by the technetium-99m as it decays.
Technetium 99m Tc albumin aggregated (99m Tc-MAA) is an injectable radiopharmaceutical used in nuclear medicine. It consists of a sterile aqueous suspension of Technetium-99m (99m Tc) labeled to human albumin aggregate particles. It is commonly used for lung perfusion scanning.
Technetium (99m Tc) exametazime is a radiopharmaceutical sold under the trade name Ceretec, and is used by nuclear medicine physicians for the detection of altered regional cerebral perfusion in stroke [1] and other cerebrovascular diseases.
Technetium (99m Tc) medronic acid is a pharmaceutical product used in nuclear medicine to localize bone metastases [1] as well as other diseases that can alter the natural turn-over in the bone by bone scintigraphy. [2]